Validation of biomarkers as early predictors of disease

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 480-481, Issue , 2001, Pages 349-358

  Bonassi, Stefano ^a   Neri, Monica ^a   Puntoni, Riccardo ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Biomarker; Longitudinal studies; Risk assessment; Validation

Indexed keywords

BIOLOGICAL MARKER; DNA;

ANALYTIC METHOD; ARTICLE; CANCER; CARDIOVASCULAR DISEASE; CHROMOSOME ABERRATION; CIRCULATION; CYTOGENETICS; DATA BASE; ENVIRONMENTAL EXPOSURE; EVALUATION; GENERAL ASPECTS OF DISEASE; HEALTH HAZARD; HUMAN; ITALY; LYMPHOCYTE; MORTALITY; OCCUPATION; PATHOGENESIS; POLICY; PRIORITY JOURNAL; PROPHYLAXIS; PUBLIC HEALTH; RISK ASSESSMENT; VALIDATION PROCESS;

EID: 0035451797     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(01)00194-4     Document Type: Article

References (43)

1. Validation of biological markers for quantitative risk assessment
2. Validation
3. Incorporating biomarker into cancer epidemiology: A matrix of biomarker and study design categories
4. Biological effect markers for exposure to carcinogenic compound and their relevance for risk assessment
5. Validity of biomarkers in environmental health studies: The case of PAHs and benzene
6. The light at the end of the tunnel for chemical-specific biomarkers: Daylight or headlight?
7. Methodological issues for biomarkers and intermediate outcomes in cohort studies
8. Transitional studies
9. The cytokinesis-block micronucleus technique: A detailed description of the method and its application to genotoxicity studies in human populations
10. The Human MicroNucleus project - An international collaborative study on the use of the micronucleus technique for measuring DNA damage in humans
11. Cytogenetic end-points as biological dosimeters and predictors of risk in epidemiological studies
12. The Human MicroNucleus project: International data base comparison for results with the cytokinesis-block micronucleus assay in human lymphocytes. Part I. Effect of laboratory protocol, scoring criteria, and host factors on the frequency of micronuclei
13. Sister chromatid exchange and micronucleus frequency in human lymphocytes of 1650 subjects in an Italian population. Part II. Contribution of sex, age, and lifestyle
14. Genetic metabolic polymorphisms and the risk of cancer: A review of the literature
15. Role of polymorphic CYP2E1 and CYP2D6 genes in NNK-induced chromosome aberrations in cultured human lymphocytes
16. Folate, Vitamin B12, homocysteine status and chromosome damage rate in lymphocytes of older men
17. Carcinogen-DNA and carcinogen-protein adducts in molecular epidemiology
18. Genetic susceptibility to lung cancer as determined by lymphocytic chromosome analysis
19. DNA adducts: Biological markers of exposure and potential applications to risk assessment
20. Correlation of DNA adduct levels in human lung with cigarette smoking
21. Molecular dosimeters of smoking damage in the lung
22. Detection of mRNA encoding xenobiotic-metabolizing cytochrome P450s in human bronchoalveolar macrophages and peripheral blood lymphocytes
23. 32P-postlabeling analysis
24. Newer saliva collection methods and saliva composition of two salivette kits
25. Comparison between smoking-related DNA adduct analysis in induced sputum and peripheral blood lymphocytes
26. Formation of cigarette smoking-induced DNA adducts in the rat lung and nasal mucosa
27. DNA adducts in human nasal mucosa and white blood cells from smokers and non-smokers
28. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma
29. Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan
30. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica
31. A genetic model for colorectal tumorigenesis
32. Chromosomal aberrations in lymphocytes predict human cancer - A report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH)
33. Are chromosome aberrations in circulating lymphocytes predictive of a future cancer onset in humans? Preliminary results of an Italian cohort study
34. Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens
35. Molecular epidemiology: On the path to prevention?
36. Benzo[a]pyrene diolepoxide - DNA adducts in alveolar macrophages of smokers
37. Validation of intermediate end points in cancer research
38. Using and interpreting surrogate end-points in cancer research
39. Genetic instability and atherosclerosis: Can somatic mutations account for the development of cardiovascular diseases?
40. Evidence for a monoclonal origin of human atherosclerotic plaques
41. The necessary role of autopsy in cardiovascular epidemiology